Saturday 17 October 2026
Export BON’s income statement to Excel — free account
Bon Natural Life Limited
BON Basic Materials Specialty Chemicals
Bon Natural Life Limited’s revenue for fiscal 2025 (year ended September 2025) was $18.7 million, down 21.7% from fiscal 2024.
1.14
0.01
+0.88%
Follow BON
| Older periods | Sep '24 | Mar '25 | Sep '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.76 | 1.38 | 0.68 | 0.70 | |
Current Ratio |
2.42 | 2.44 | 1.74 | 1.83 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
2.32% | 1.61% | 2.26% | 2.44% | |
Debt/Equity |
0.03 | 0.02 | 0.03 | 0.04 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | — | |
Capex/Depreciation |
(0.01) | 0.01 | (3.40) | — | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.08 | 0.08 | |
Share Based Compensation of Revenue |
— | 0.00% | — | — | |
Free Cash Flow Yield |
— | — | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | — | |
Capex per Share |
0.00 | 0.00 | 0.00 | — | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | — | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(7.73) | (4.29) | (4.23) | — | |
Working Capital |
23.35 | 25.06 | 19.45 | 23.02 | |
Capital Expenditures |
(0.01) | 0.00 | (4.37) | — | |
Net Current Asset Value |
22.38 | 24.79 | 18.57 | 21.45 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | |
| Other line items | |||||
Average Receivables |
9.30 | 12.17 | 8.08 | 9.27 | |
Average Payables |
1.82 | 1.19 | 4.52 | 4.94 | |
Average Inventory |
1.65 | 2.24 | 2.15 | 2.58 | |
Average Assets |
49.51 | 59.40 | 65.87 | 65.14 | |
Average Common Equity |
37.22 | 44.70 | 46.99 | 44.05 |
Columns are period end dates · fundamentals updated 28 Sep 2026